Altimmune Stock Potential For Pemvidutide In Obesity, NASH - Seeking Alpha
| K41 Stock | 0.81 0.02 2.41% |
Roughly 62% of SCANDMEDICAL SOLDK-040's investor base is looking to short. The analysis of current outlook of investing in SCANDMEDICAL SOLDK 040 suggests that many traders are alarmed regarding SCANDMEDICAL SOLDK-040's prospects. The current market sentiment, together with SCANDMEDICAL SOLDK-040's historical and current headlines, can help investors time the market. In addition, many technical investors use SCANDMEDICAL SOLDK 040 stock news signals to limit their universe of possible portfolio assets.
SCANDMEDICAL SOLDK-040 stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SCANDMEDICAL daily returns and investor perception about the current price of SCANDMEDICAL SOLDK 040 as well as its diversification or hedging effects on your existing portfolios.
SCANDMEDICAL |
Altimmune Stock Potential For Pemvidutide In Obesity, NASH Seeking Alpha
Read at news.google.com
 |
SCANDMEDICAL SOLDK-040 Fundamental Analysis
We analyze SCANDMEDICAL SOLDK-040's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SCANDMEDICAL SOLDK-040 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SCANDMEDICAL SOLDK-040 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
SCANDMEDICAL SOLDK is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
SCANDMEDICAL SOLDK 040 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SCANDMEDICAL SOLDK-040 stock to make a market-neutral strategy. Peer analysis of SCANDMEDICAL SOLDK-040 could also be used in its relative valuation, which is a method of valuing SCANDMEDICAL SOLDK-040 by comparing valuation metrics with similar companies.
Peers
SCANDMEDICAL SOLDK-040 Related Equities
| 2DG | SIVERS SEMICONDUCTORS | 20.00 | ||||
| 6NM | NMI Holdings | 3.26 | ||||
| 8SP | Superior Plus | 0.96 | ||||
| SYK | Stryker | 0.11 | ||||
| GOV | Insulet | 0.04 | ||||
| AFW | Align Technology | 0.46 | ||||
| TLX | Talanx AG | 0.81 | ||||
| TM9 | NorAm Drilling | 3.38 | ||||
| INVN | Identiv | 3.86 | ||||
| 39O1 | Origin Agritech | 4.48 |
Complementary Tools for SCANDMEDICAL Stock analysis
When running SCANDMEDICAL SOLDK-040's price analysis, check to measure SCANDMEDICAL SOLDK-040's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SCANDMEDICAL SOLDK-040 is operating at the current time. Most of SCANDMEDICAL SOLDK-040's value examination focuses on studying past and present price action to predict the probability of SCANDMEDICAL SOLDK-040's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SCANDMEDICAL SOLDK-040's price. Additionally, you may evaluate how the addition of SCANDMEDICAL SOLDK-040 to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |